Literature reference · Endocrinology
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
PubMed · Retrieved 2026-10-13
Bibliographic record: The New England journal of medicine (2023 Dec 14). PMID 37952131. DOI 10.1056/NEJMoa2307563.
Reference details
- Authors
- A Michael Lincoff; Kirstine Brown-Frandsen; Helen M Colhoun; John Deanfield; Scott S Emerson; Sille Esbjerg; Søren Hardt-Lindberg; G Kees Hovingh; Steven E Kahn; Robert F Kushner; Ildiko Lingvay; Tugce K Oral; Marie M Michelsen; Jorge Plutzky; Christoffer W Tornøe; Donna H Ryan; SELECT Trial Investigators
- Journal
- The New England journal of medicine
- Publication date
- 2023 Dec 14
- PMID
- 37952131
- DOI
- 10.1056/NEJMoa2307563
- Volume
- 389
- Issue
- 24
- Pages
- 2221
- Language
- eng
- Publication types
- Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
- MeSH subjects
- Humans; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Glucagon-Like Peptides; Hypoglycemic Agents; Myocardial Infarction; Obesity; Overweight; Stroke; Glucagon-Like Peptide-1 Receptor Agonists; Cardiovascular Agents; Semaglutide
Citation
Indexed subjects
Access and reuse
Sources and reuse
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-06-18. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.